Description
Caffeoyltryptophan is a competitive PTP1B inhibitor, with an IC50 of 16.99 µM. Caffeoyltryptophan can also inhibit α-glucosidase, linoleic acid peroxidation and haemolysis. Caffeoyltryptophan can be used for the research of type 2 diabetes[1]